Breathe Well Live Well
Condition: Asthma
Interventions: Drug: NVA237; Drug: Placebo to NVA237; Drug: salbutamol/ albuterol
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention:
Sponsor: Chiesi Farmaceutici S.p.A.
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Drug Allergy
Intervention: Drug: Omalizumab
Sponsors: Dana-Farber Cancer Institute; Novartis Pharmaceuticals
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Another Voice: 'Study' was meant to disguise asthma problems caused by Peace …
Buffalo News Scientific studies conducted by local asthma doctor and researcher Dr. Jamson Lwebuga-Mukasa build a strong case for a link between Peace Bridge traffic and asthma prevalence on the Lower West Side. A survey of 2,000 randomly selected households … |
View full post on asthma – Google News
Condition: External Cephalic Version
Interventions: Drug: Intravenous Terbutaline; Drug: Intravenous Nitroglycerine
Sponsors: Mount Sinai School of Medicine; Yaakov Beilin
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Medical Daily |
Asthma linked to increased risk for bone loss, study says
Fox News People with asthma-related breathing problems may be at increased risk for bone loss, according to a new study. The study examined the records of more than 7,000 adults in Seoul, Korea, and found those with a certain characteristic of asthma had … Study ties breathing problems, asthma to bone loss Asthma May Up Risk Of Bone Loss, Osteoporosis |
View full post on asthma – Google News
|
Cytos hits the self-destruct button as PhIIb asthma study bombs
FierceBiotech The Swiss biotech said that its asthma drug CYT003 flunked its primary as well as secondary endpoints in the critically important study, making it all but impossible to raise more funds for the company. As a result, CEO Christian Itin has hit the self … Cytos Begins Layoff Process, Eyes Liquidation After Phase IIb Failure Cytos considering options to wind down company |
View full post on asthma – Google News
|
Study ties breathing problems, asthma to bone loss
Yahoo News NEW YORK (Reuters Health) – People with asthma-related breathing problems may be at increased risk for bone loss, according to a new study. The study examined the records of more than 7,000 adults in Seoul, Korea, and found those with a certain … |
View full post on asthma – Google News
|
Study ties breathing problems, asthma to bone loss
Reuters The study examined the records of more than 7,000 adults in Seoul, Korea, and found those with a certain characteristic of asthma had significantly lower bone density in a region of their spine than those without asthma symptoms. The characteristic … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Budesonide Inhalation Aerosol (PT008) Dose 1; Drug: Budesonide Inhalation Aerosol (PT008) Dose 2; Drug: Budesonide Inhalation Aerosol (PT008) Dose 3; Drug: Budesonide Inhalation Aerosol (PT008) Dose 4; Drug: Placebo
Sponsor: Pearl Therapeutics, Inc.
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days